Founded in 2010 by interdisciplinary scientists and expert returnees in the fields of medicine, physics, biochemistry, etc., ANPAC is considered as one of the pioneers and main leaders of multi(pan)-cancer detection and multi-dimensional multi-parameter cancer screening theories and methods.

Over the past decade, ANPAC has focused on major innovation, with a multi-disciplinary approach combining biochips, biophysical and biomedical technologies, ANPAC has overcome the technical challenges of early cancer screening.

CDA Early Cancer Risk Assessment

CDA and Gene combination test

APCS Pan-Cancer Screening

CDA and Gene combination test

ADME Third Immune Defense Test

CDA and Gene combination test

Hot News

Hot Video


Shanghai Changzheng Hospital
Fudan University Science Life Of School
Changhai Hospital
Shanghai Tumor Hospital
Shanghai Jiaotong University School Of Medicine